Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InhaleRx Limited ( (AU:IRX) ) has provided an announcement.
InhaleRx Limited has announced a proposed issue of securities, which includes 2,324,926 performance rights in lieu of director fees and 1,000,000 unlisted options at $0.12 expiring on July 7, 2028. This strategic move is aimed at optimizing the company’s financial structure and incentivizing its leadership, potentially impacting its market positioning and stakeholder confidence.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based drug delivery systems. The company aims to provide innovative solutions for respiratory and other medical conditions, leveraging its expertise in inhalation technology.
Average Trading Volume: 318,939
Technical Sentiment Signal: Buy
Current Market Cap: A$8.54M
For detailed information about IRX stock, go to TipRanks’ Stock Analysis page.